Veterinary Medicines

TOXIPRA PLUS SUSPENSION INYECTABLE PARA BOVINO, CAPRINO, OVINO, PORCINO Y CONEJOS

Authorised
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium perfringens, type B, C and D, epsilon toxoid
  • Clostridium perfringens, type B, C and D, beta toxoid
Download as PDF

Product identification

Medicine name:
TOXIPRA PLUS SUSPENSION INYECTABLE PARA BOVINO, CAPRINO, OVINO, PORCINO Y CONEJOS
Active substance:
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium perfringens, type B, C and D, epsilon toxoid
  • Clostridium perfringens, type B, C and D, beta toxoid
Target species:
  • Cattle (calf)
  • Sheep (lamb)
  • Pig (piglet)
  • Rabbit (female for reproduction)
  • Goat (kid)
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    100.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, type B, alpha toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, C and D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, C and D, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • LABORATORIOS HIPRA, S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2820 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 28/05/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 28/05/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."